baber/WOPTO huggingface dataset:
Patent PT-1244529-E (PT)
Inventor: ZUBCEVIC ESAD
IPC: B21D19/00
Filed: 2000-12-22
Abstract: A method for fastening a bottom part (40) to a can body (31). The method comprises positioning the bottom part at one end of the can body such that a rim portion of the bottom part is in abutting engagement with a radial flange formed at said one end, rotating the can body in relation to at least one bending or folding tool (43-45), and moving said bending or folding tool radially in relation to the can body along a predetermined path corresponding to the cross sectional shape of the can body, so as to fasten the bottom part to the can body. <??>Furthermore the invention relates to an apparatus (13) for fastening a can bottom to a can body having a non-circular cross-sectional shape. The apparatus comprises means for rotating a can body with a can bottom positioned at one end thereof such that a rim portion of the bottom is in abutting engagement with a radial flange formed at said one end of the can body, at least one bending or folding tool (43-45) movable radially in relation to the can body positioned on said rotating means, and means (46) for moving or biasing the bending or folding tool radially into engagement with said rim portion and/or with said radial flange (41,42), so as to bend or fold said rim portion and/or said flange. <??>Additionally the invention relates to a can making facility comprising the aforementioned apparatus.A method for fastening a bottom part (40) to a can body (31). The method comprises positioning the bottom part at one end of the can body such that a rim portion of the bottom part is in abutting engagement with a radial flange formed at said one end, rotating the can body in relation to at least one bending or folding tool (43-45), and moving said bending or folding tool radially in relation to the can body along a predetermined path corresponding to the cross sectional shape of the can body, so as to fasten the bottom part to the can body. <??>Furthermore the invention relates to an apparatus (13) for fastening a can bottom to a can body having a non-circular cross-sectional shape. The apparatus comprises means for rotating a can body with a can bottom positioned at one end thereof such that a rim portion of the bottom is in abutting engagement with a radial flange formed at said one end of the can body, at least one bending or folding tool (43-45) movable radially in relation to the can body positioned on said rotating means, and means (46) for moving or biasing the bending or folding tool radially into engagement with said rim portion and/or with said radial flange (41,42), so as to bend or fold said rim portion and/or said flange. <??>Additionally the invention relates to a can making facility comprising the aforementioned apparatus. <IMAGE> <IMAGE>
Patent PT-1257773-E (PT)
Title: Heat exchange pipe with extruded fins
Inventor: KINCHELOE DAVID P
IPC: F28F1/22
Filed: 2001-02-13
Abstract: An apparatus and method for cooling the interior wall of an electric arc furnace. The device is an extruded heavy-walled pipe having a base and a fin or plurality of fins. Such pipes are attached to a plate in serpentine fashion and hung on the inside wall of the electric arc furnace above the hearth, thereby forming a cooling surface between the interior and the furnace wall. The fins are sized and arranged to retain splattered slag. The slags solidifies on the pipes, forming an insulation barrier between the molten iron material and the cooling pipes and, consequently, the wall of the furnace.
Patent PT-1326571-E (PT)
Title: An easily carried eye rinsing device
Inventor: AHLSTROEM TOM
IPC: B65D47/18
Filed: 2001-10-16
Abstract: An easily carried eye rinsing device in the form of a flask containing an eye rinsing liquid. The flask is sealed by a closure element that projects up from a future opening of the flask. An eye cup surrounds the closure element and a sleeve surrounds the eye cup. The sleeve is non-rotatably connected with the closure element.
Patent PT-1358127-E (PT)
Inventor: DENNIS STAMIRES
IPC: C01B13/32
Filed: 2002-01-29
Abstract: The present invention is directed to a process for the preparation of crystalline anionic clay-containing bodies from sources comprising a trivalent metal source and a divalent metal source comprising the steps of: a) preparing a precursor mixture containing a liquid, a divalent metal source and/or a trivalent metal source, at least one of them being insoluble in the liquid; b) shaping the precursor mixture to obtain shaped bodies; c) optionally thermally treating the shaped bodies; and d) aging the shaped bodies to obtain crystalline anionic clay-containing bodies; with the proviso that if no trivalent metal source is present in the precursor mixture of step a), such source is added to the shaped bodies after shaping step b) and before aging step d); and with the further proviso that the combined use of an aluminium source as the trivalent metal source and a magnesium source as the divalent metal source is excluded. The quintessence of the present invention is that the major part of the final amount of anionic clay is formed after shaping, i.e., in situ in the shaped body. This results in attrition resistant bodies, without the need to add a binder material.
Patent PT-1362844-E (PT)
Title: Benzylamine analogue
Inventor: KOGEN HIROSHI
IPC: C07D401/06
Filed: 2002-01-22
Abstract: A compound of the formula (I): <CHEM> Äwherein R<1> represents a C1-C6 alkyl group etc., R<2> and R<3> are the same or different and represent a hydrogen atom etc., R<a> represents a C1-C6 alkyl group etc., Arom represents an aryl group etc., A represents a C1-C6 alkylene group, E represents a single bond, an oxygen atom, a sulfur atom etc., X<1> and X<2> are the same or different and represent an oxygen atom or a sulfur atomÜ or a pharmacologically acceptable salt or ester thereof.
Patent PT-1480961-E (PT)
Title: Glutaminyl based dpiv inhibitors
Inventor: DEMUTH HANS-ULRICH
IPC: C07D295/185
Filed: 2002-06-27
Abstract: The present invention provides compounds of the formula: wherein X=CH<SUB>2 </SUB>or S or pharmaceutical acceptable salts thereof useful for treating conditions mediated by DPIV or DPIV-like enzymes, such as arthritis, obesity, immune and autoimmune disorders, allograft transplantation, cancer, neuronal disorders and dermal diseases.
Patent PT-1448345-E (PT)
Inventor: ROFFAEL EDMONE
IPC: B27N1/00
Filed: 2002-11-09
Abstract: Die Erfindung betrifft ein Verfahren zur Hydrophobierung von Lignocellulosen und einen Holzwerkstoff aus Lignocellulosen. Die Lignocellulosen werden mit einem Hydrophobierungsmittel auf Paraffinbasis versehen und danach, gegebenenfalls nach einem Trocknungsvorgang, zu dem Holzwerkstoff zusammengepresst. Von Bedeutung ist, dass das Hydrophobierungsmittel zumindest teilweise FT-Paraffin ist.
Patent PT-1408270-E (PT)
Inventor: HOLT EARL R
IPC: B05B12/08
Filed: 1996-07-17
Abstract: The assembly includes a quick disconnect connection (130) having a first fluid bore extending through it, this connection including first closure member (158) movably positioned between a first position and a second position in the first fluid bore for preventing and permitting fluid to pass through the first fluid bore. There is also a quick disconnect stem (134) having a second fluid bore extending through, the stem including a second closure member movably positioned between a third position and a fourth position in the second fluid bore for preventing and permitting fluid to pass through the second fluid bore. Upon connecting the quick disconnect connection with the quick disconnect stem, the first closure member is moved to the second position and the second closure member is moved to the fourth position to permit fluid to pass through the first and second fluid bores.
Patent PT-1542741-E (PT)
Title: Device and method for separating blood into leukocyte depleted blood components
Inventor: MARI GIORGIO
IPC: B01D35/02
Filed: 2003-09-19
Abstract: A device for separating blood into blood components comprising:-a collecting container ( 2 ) for receiving blood (WB),-a first satellite container ( 4 ) connected, in fluid flow communication, to said collecting container ( 2 ) through a leukocyte filter ( 22 ) for receiving from said collecting container ( 2 ) a leukocyte depleted first blood component (PRP),-a second satellite container ( 6 ) connected, in fluid flow communication, with said collecting container ( 2 ) through said filter ( 22 ) for receiving from said collecting container a second leukocyte depleted blood component (PRC), and flow control means ( 36, 38, 42 ) for allowing fluid flow from said collecting container selectively into said first ( 4 ) or second ( 6 ) satellite container through said leukocyte filter ( 22 ), whereby whole blood (WB) can be separated into a first (PRP) and second (PRC) leukocyte depleted blood component with a single leukocyte filter ( 22 ). Preferably the second satellite container ( 6 ) is further connected to said collecting container ( 2 ) through conduit means ( 28 b, 34, 16 a) by-passing said filter ( 22 ), and the valve means are further adapted for allowing the transfer of an additive from said second satellite container ( 6 ) into said collecting container ( 2 ) only through said conduit means ( 28 b, 34, 16 a) bypassing said filter ( 22 ).
Patent PT-1587514-E (PT)
Inventor: CHRISTER NYSTROEM
IPC: A61K9/20
Filed: 2004-01-15
Abstract: A pharmaceutical composition for the treatment of acute disorders is described. The composition comprises an essentially water-free, ordered mixture of at least one pharmaceutically active agent in the form of microparticles which are adhered to the surfaces of carrier particles which are substantially larger than the particles of the active agent or agents, and are essentially insoluble or sparingly soluble in water, in combination with a bioadhesion and/or mucoadhesion promoting agent adhered to the surfaces of said carrier particles. The composition is primarily intended for sublingual or intranasal administration. The invention also relates to a method for preparing the composition and to the use of the composition for the treatment of acute disorders.
Patent PT-1601355-E (PT)
Title: Diagnostic method for prevision of kidney transplantation rejection
Inventor: SERIO MARIO
IPC: A61K31/4439
Filed: 2004-03-02
Abstract: The use of thiazolidinediones for the preparation of pharmaceutical compositions useful for the treatment of endocrine autoimmune diseases, in particular Graves' disease, is described.
Patent PT-1628585-E (PT)
Title: A set of surgical devices for cutaneous detachment of skin
Inventor: LUZ DILSON FERREIRA DA
IPC: A61B17/00
Filed: 2004-04-13
Abstract: The present invention refers to a device and a method for subcutaneous detachment of the face, the leg, the thigh, the breast, the abdomen and the forehead, facilitating the full detachment of the skin from the underlying (adipose) tissue with substantial reduction in bleeding, better skin cutting quality, lesser amount of post-op edema, decreased surgery time, minimization of ecchymoses, prophylaxis of facial nerve injuries, and above all, minimized formation of post-op hematomas.
Patent PT-1765600-E (PT)
Title: Anti-counterfeit security object and methods for its production and verification
Inventor: HEIERLI RENE
IPC: G07D7/12
Filed: 2004-06-30
Abstract: The security object comprises a substrate, a surface structure and a hologram layer. A volume hologram is arranged in the hologram layer. The hologram layer is deformed in homogeneously by the surface structure, which gives rise to readily detectable changes in the reflections from the volume hologram. These changes can be used to verify the authenticity of the object. The surface structure can e.g. be applied using intaglio printing techniques or embossing. Alternatively or in addition to the deformation of the hologram layer by means of the surface structure, the hologram layer may also be deformed by embossing.
Patent PT-1697443-E (PT)
Title: Bacteria support material
Inventor: GIANGRASSO ANTONIO
IPC: C04B38/00
Filed: 2004-12-22
Abstract: The present invention relates to a composite material made of non-metallic inorganic grains and plastics particles. The composite material is particularly suitable as a carrier material for bacteria for use in sewage treatment plants. It is characterized by a large surface suitable for the colonization of bacteria and also by a density which allows the composite material to be suspended in the medium present in the sewage treatment plant. A further advantage of the composite material according to the invention is the property that due to the surface structure of the composite material adhering sludge and saturated bacteria can fall off its surface, and this thus allows regeneration of the material.
Patent PT-1838677-E (PT)
Title: Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
Inventor: AGARWAL RAJESH KUMAR
IPC: A61P3/04
Filed: 2005-12-20
Abstract: The present invention is a process for preparing crystalline form of ( R )-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate.
Patent PT-2073432-E (PT)
Title: Method for binding an access terminal to an operator and corresponding access terminal
Inventor: ZHANG KE
IPC: H04L9/32
Filed: 2007-09-25
Abstract: An access terminal and a method for binding the access terminal to an operator are provided. The method mainly includes the following steps. A broadband access server (BAS) receives a packet, encrypts private information in the packet using an agreed encryption algorithm, and then sends the encrypted information to the access terminal through a response packet. The access terminal encrypts the private information using the agreed encryption algorithm, and compares the encrypted private information with the encrypted information carried in the response packet. If the two are different, a dial-up process is ended or a link is removed. The technical solutions of the present invention can effectively prevent the user from using an access terminal provided by the current operator to access networks of other operators, so as to avoid vicious competition between the operators. Moreover, the present invention is simply achieved without changing the networking mode and the user's habit, and has no demand of service distribution.
Patent PT-1994911-E (PT)
Title: Repositionable and recapturable vascular stent/graft
Inventor: AMPLATZ KURT
IPC: A61M25/09
Filed: 2001-03-12
Abstract: A collapsible medical device (10) for grafting a lumen of selected organs and vessels, wherein the medical device (10) is shaped from a shape memory fabric. The device (10) is preferably made from a continuous tubular fabric (12) and each end terminates with an open end (14, 16) for passage there through. Each end (14, 16) further includes a securing member (24) attached to an outer perimeter of the end, wherein a substantial plane formed by the perimeter intersects the longitudinal axis of the tubular fabric (12) at either an acute or obtuse angle. The fabric may be heat treated within a mold in order to substantially set a desired shape of the device (10). The securing member (24) may also attach to the end of a guide wire or delivery catheter, thereby allowing deployment and later retrieval after deployment of the device (10).
Patent PT-1990343-E (PT)
Title: Azaindoles
Inventor: COX PAUL JOSEPH
IPC: A61K/
Filed: 2000-12-27
Abstract: The invention is directed to compositions containing physiologically active compounds of general formula (I) wherein R1 is aryl or heteroaryl; R2 represents hydrogen, acyl, cyano, halo, lower alkenyl or lower alkyl optionally substituted by a substituent selected from cyano, heteroaryl, heterocycloalkyl, -Z1R8,-C(=O)-NY3Y4,-CO2R8,-NY3Y4,-N(R6)-C(=O)-R7, -N(R6)-C(=O)-NY3Y4,-N(R6)-C(=O)-OR7, -N(R6)-SO2-R7,-N(R6)-SO2-NY3Y4 and one or more halogen atoms; R3 represents hydrogen, aryl, cyano, halo, heteroaryl, lower alkyl, -C(=O)-OR5 or -C(=O)-NY3Y; and X1 represents N, CH, C-halo, C-CN, C-R7, C-NY3Y4, C-OH, C-Z2R7, C-C(=O)-OR5, C-C(=O)-NY3Y4, C-N(R8)-C(=O)-R7, C-SO2-NY3Y4, C-N(R8)-SO2-R7, C-alkenyl, C-alkynyl or C-NO2; and their produgs, and pharmaceutically acceptable salts and solvates of such compounds and their produgs, as well as to novel compounds within the scope of fomula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
Patent PT-604355-E (PT)
Inventor: MOLDT PETER
IPC: A61P25/26
Filed: 1993-12-20
Abstract: The present invention discloses compounds of the formula <CHEM>  any mixture thereof, or a pharmaceutically acceptable salt thereof; wherein R, R<3>, and R<4> each have the meanings set forth in the specification. The compounds possess valuable pharmaceutical properties as dopamine reuptake inhibitors.
Patent PT-796262-E (PT)
Inventor: BUYNAK JOHN D
IPC: C07D501/58
Filed: 1995-12-11
Abstract: Derivatives of 7-alkylidene cephalosporanic acid sulfone and the pharmaceutically active salts thereof are found to be potent inhibitors of  beta -lactamase enzymes.
Patent PT-871718-E (PT)
Title: Production of enzymatically active recombinant carboxypeptidase b
Inventor: HARTMAN JACOB
IPC: C12R1/19
Filed: 1996-01-25
Abstract: The subject invention provides a method of producing enzymatically active CPB which comprises treating a recombinant cell containing DNA encoding ProCPB, so that the DNA directs expression of the ProCPB, recovering from the cell the ProCPB so expressed, treating the recovered ProCPB under conditions permitting folding of the ProCPB, subjecting the folded ProCPB to enzymatic cleavage to produce enzymatically active CPB and purifying the enzymatically active CPB.
Patent PT-929486-E (PT)
Inventor: BERNARD FREDERIC
IPC: B65G51/03
Filed: 1997-06-04
Abstract: A device for conveying objects having a neck along a given direction having at least one pressure chamber capable of projecting an air flow on the objects along the conveying direction, and a support rail oriented along the conveying direction. The device includes transport shuttles fixed to the neck of the objects and cooperating with the support rail.
Patent PT-923366-E (PT)
Inventor: MAMMONE THOMAS
IPC: A61P17/00
Filed: 1998-03-03
Abstract: The present invention relates to a protection-effective amount of UV-damaged RNA fragments, in combination with a cosmetically or pharmaceutically acceptable carrier. The compositions are useful in the prevention of skin damage to UV radiation and in preventing photoaging.
Patent PT-1001775-E (PT)
Inventor: GORNY PHILIPPE
IPC: A61K31/475
Filed: 1998-07-06
Abstract: The invention concerns the use in combination of yohimbine and arginine as active ingredients for preparing a medicine for treating erectile dysfunction. The combination has a marked synergistic effect.
Patent SG-74192-G (SG)
Title: Processing paper and other webs
IPC: B65H19/10
Filed: 1992-07-17
Abstract: A printing apparatus has an array of cartridges (40,41,42) for printing a web (2) of e.g. paper passing through the array, and one or more units (48,49) containing printing medium. The cartridges (40,41,42) each are capable of transferring the printing medium from the units(s) (48,49) to the web (2). The unit(s) (48,49) and the cartridges (40,41,42) of the array are relatively movable, to allow the unit(s) (48,49) to interact successively with at least two of the cartridges (40,41,42). In this way it is possible to change printing from one cartridge (40,41,42) to another, allowing changes to be made to what is printed, without halting the movement of web (2) significantly. The present invention also proposes that the cartridges (40,41,42) may have printing cylinders (43,44,45,46) of different sizes, and furthermore that a mobile unwind stand may be used to move web material to the printing apparatus, and the web output from the printing apparatus processed by sheet folding techniques.
Patent IE-38740-L (IE)
Title: Fat blend
IPC: A23D7/00
Filed: 1974-01-14
Abstract: 1455828 Fat blend UNILEVER Ltd 17 Jan 1974 [18 Jan 1973] 2667/73 Heading C5C A fat blend for margarine comprises a palm based fat and a co-randomized mixture of a palm based fat and a non-palm based fat, the non-palm based fat predominantly consisting of C 44 and higher triglycerides (defined), 40-80 wt. per cent of the total fatty acid residues in ihe blend being derived from palm based fat and the fat blend having a PUP/PPU ratio (defined) of #2À8. The exemplified non-palm based fats are soyabean, safflower, sunflower, rapeseed, cotton seed ground nut and rice bean oil and marine oils and their hydrogenated or fractionated derivatives.
[GB1455828A]
Patent IE-850203-L (IE)
Title: Preparing phosphonic acid diesters
IPC: C07F9/38
Filed: 1985-01-29
Abstract: Phosphonic acid diesters having the formula:   <IMAGE>  in which R represents a hydrogenolysable group, preferably an aralkyl group, and R<1> represents a hydrolysable group, are obtained by a process wherein phosphonic acid esters of the formula (R<1>O)2P(O)H are reacted with formaldehyde and compounds of the formula R-NH-CH2-COOH, R and R<1> having the meanings given above. Compounds of the formula   <IMAGE> may be obtained by hydrogenolysis of the above compounds.
Patent IE-37348-L (IE)
Title: Suture package
IPC: B65D75/38
Filed: 1973-02-13
Abstract: A surgical suture package, primarily for double armed multi-strand sutures, retains each individual suture in a predetermined sinusoidal configuration within adjacent but separate compartments. Notches along one edge of the package secure the armed ends of each suture which are held in place within the package when the compartments are folded together. As the package is unfolded, the armed ends are exposed sequentially, facilitating removal by the surgeon of each suture from its compartment one at a time without tangling and kinking.
[US3759376A]
Patent IE-810349-L (IE)
Title: Cyclopentanopyrrolines.
IPC: C07D209/52
Filed: 1981-02-20
Abstract: What are disclosed are prostacylin PGI2 analogs of the formula <IMAGE>   having a more specific or longer lasting pharmacological action than PGI2, methods of making these analogs; and methods and pharmaceutical preparations for inhibiting blood platelet aggregation, for treating hypertension, for the treatment or prophylaxis of gastrointestinal ulcers, and for the treatment of asthma.
Patent IE-33371-L (IE)
Title: Protozoacids; aminoguanidine derivatives
IPC: C07C239/00
Filed: 1969-06-19
Abstract: 1,256,723. Antiprotozoal compositions. AMERICAN CYANAMID CO. 23 June, 1969 [1 July, 1968], No. 31664/69. Heading A5B. [Also in Division C2] Antiprotozoal compositions comprise as active ingredient a compound of formula I: (in which each of R 1 and R 5 is halogen, CF 3 or ON, each of R 2 and R 6 is H or halogen, each of R 3 , R 4 , R 7 and R 8 is H or C 1-4 alkyl and R 9 is H or C 2-5 alkanoyl) or a pharmacologically acceptable, acid addition salt thereof, and a pharmaceutical carrier. The compositions may be administered orally or parenterally.
[GB1256723A]